Hematologic Malignancy
📧 Sign up to get email alerts when something new happens for Hematologic Malignancy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCT [Phase 3]
A Phase 3 trial update suggests that a CMV-specific T cell immunity test could indicate prophylaxis with letermovir after allogeneic hematop…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Information and Accompaniment of Siblings Following the Announcement of a Cancer in Pediatric Hematology. [NA]
The clinical trial NCT03541330 sponsored by University Hospital Lille was terminated; the study concerned information and support for siblin…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Predicting the Impact of Treatment Toxicities on Health During Cancer ( PATTERN )
A completed clinical trial (NCT05790538) investigating methods to predict how cancer treatment toxicities affect patients' health.
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Rose Geranium in Sesame Oil Nasal Spray for the Improvement of Nasal Vestibulitis Symptoms in Cancer Patients Receiving Chemotherapy [Phase 3]
A Phase 3 clinical trial evaluating a rose geranium in sesame oil nasal spray for improving nasal vestibulitis symptoms in cancer patients u…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients [NA]
A study evaluating low-intensity mechanical stimulation for patients with hematologic malignancies is currently recruiting. The sponsor is R…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Impact of Congenital Heart Disease on the Prognosis of Childhood Hematological Neoplasms: A Multicenter Cohort Study
A multicenter cohort study evaluated how congenital heart disease influences prognosis in childhood hematologic malignancies.
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol [Phase 2, Phase 3]
The DETERMINE master screening protocol is a platform trial designed to determine extended therapeutic indications for existing drugs in rar…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Expressive Writing for the Management of Stress in Cancer Survivors [NA]
The study 'Expressive Writing for the Management of Stress in Cancer Survivors' is currently recruiting, sponsored by MD Anderson Cancer Cen…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation Oncology
This ClinicalTrials.gov entry reports a survey evaluating patient and provider impressions of telemedicine in radiation oncology. Sponsored …
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial [Phase 2]
Phase 2 trial evaluating the combination of talazoparib and temozolomide in advanced, rare cancers; the study is currently active but not re…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy [Phase 2]
Phase 2 clinical trial evaluating salvage radiation therapy for patients with metastatic cancer that progressed after systemic immunotherapy…
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I) [Phase 2]
Phase 2 MATCH subprotocol Z1I study evaluating AZD1775 (adavosertib) as a targeted treatment for cancers with BRCA genetic changes. The tria…
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: Acupressure for Reducing Anxiety in Patients Undergoing Chemotherapy [NA]
A completed clinical trial evaluated acupressure as a method to reduce anxiety in patients undergoing chemotherapy.
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: Virtual Mindfulness and Weight Management to Mitigate Risk of Relapse and Improve Wellbeing in Cancer Survivors [NA]
A completed Mayo Clinic trial evaluated virtual mindfulness and weight management to reduce relapse risk and improve wellbeing in cancer sur…
-
CLINICAL_TRIALS research · 2025-10-21Clinical Trial Update: The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors
ClinicalTrials.gov entry for a recruiting study led by M.D. Anderson Cancer Center evaluating the impact of the COVID-19 pandemic on adolesc…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: BMT-CARE: Psychosocial Intervention for Transplant Caregivers [NA]
A Massachusetts General Hospital-sponsored clinical trial called BMT-CARE is evaluating a psychosocial intervention for caregivers of bone m…
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant [Phase 1, Phase 2]
Phase 1b/2a randomized double-blind trial to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of …
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Telerehabilitation in Hemato-oncological Survivors [NA]
This entry describes a study evaluating telerehabilitation for survivors of hematologic malignancies and lymphoma, which is currently recrui…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Home Transfusion for HEME [NA]
A completed clinical trial update from the Dana-Farber Cancer Institute regarding home transfusion for hematologic malignancies.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: HEME Home Transfusion Program [NA]
Clinical trial update indicates that the HEME Home Transfusion Program is currently recruiting for hematologic conditions including leukemia…
-
CLINICAL_TRIALS withdrawal · 2025-09-04Clinical Trial Update: Major Complication Rate in Cancer Patients With Neutropenic Fever Potentially Eligible for a Hospital at Home Program
Clinical trial NCT04557709, sponsored by MD Anderson Cancer Center, evaluating major complication rate in cancer patients with neutropenic f…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Weighted Blanket Use to Reduce Anxiety in Oncology Patients [NA]
A clinical trial is assessing whether weighted blankets can reduce anxiety in oncology patients and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer [EARLY_Phase 1]
Early-phase trial evaluating levorphanol as a second-line opioid for cancer pain has been terminated; no results are provided in this update…
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Hospital at Home at EOL in Heme Malignancies [NA]
The Massachusetts General Hospital trial evaluating hospital-at-home care at end-of-life for hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain [Phase 1]
Phase 1 trial evaluating psilocybin plus multidisciplinary palliative care in demoralized cancer survivors with chronic pain has completed.